| Eliana Bojkova, PSY D | |
|
30 Warren St, Franciscan Hospital For Children, Brighton, MA 02135-3602 | |
| (617) 254-3800 | |
| Not Available |
| Full Name | Eliana Bojkova |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 30 Warren St, Brighton, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255664454 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 9047 (Massachusetts) | Primary |
| 103T00000X | Psychologist | 017786 (New York) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Eliana Bojkova, PSY D 1957 Commonwealth Ave, Apt 1, Brighton, MA 02135-5923 Ph: (609) 356-9834 | Eliana Bojkova, PSY D 30 Warren St, Franciscan Hospital For Children, Brighton, MA 02135-3602 Ph: (617) 254-3800 |
News Archive
In work that could lead to new treatments for sensory disorders in which people experience the strange phenomena of seeing better with one eye covered, MIT researchers report that they have identified the gene responsible for binocular vision.
MorphoSys AG and Boehringer Ingelheim announced today the signing of a biopharmaceutical manufacturing agreement for therapeutic antibodies. The agreement covers the process development and manufacturing of additional clinical material for MorphoSys's proprietary MOR208 program and other drug candidates. MOR208, a potent monoclonal anti-CD19 antibody, is in development for the treatment of chronic lymphocytic leukemia and potentially other B-cell malignancies. The program is currently being evaluated in a phase 1 clinical trial in the USA by MorphoSys's partner Xencor Inc.
A team of researchers recently discussed the potential role of a new assay in bridging a major gap in SARS-CoV-2 research. This assay can throw light on 1) the selection of complementary monoclonal antibody candidates and 2) rapid identification of the immune escape to emerging RBD variants following vaccination or natural infection.
Scientists are reporting development of a new form of aspirin - taken daily by about 60 million people in the United States alone to reduce the risk of heart attack and stroke - that could extend aspirin's benefits to people who may not respond to the drug. Their advance toward coping with "aspirin resistance" appears in the journal ACS Nano.
This e-compendium solution was also unique internationally when we launched it,» reports Atle Løkken, head of the NettOp department for web-based learning at the UiS.
› Verified 9 days ago
Aberdine Rhiannon Donaldson, NCSP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 30 Warren St, Brighton, MA 02135 Phone: 617-254-3800 | |
Dr. Sheryl Thau Bardin, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 17 Henshaw St, Brighton, MA 02135 Phone: 617-332-0205 | |
Dr. Kenneth A Larsen, DMIN, PHD, ABMP Psychologist Medicare: Accepting Medicare Assignments Practice Location: 20 Guest St, Ste 225, Brighton, MA 02135 Phone: 617-754-5160 Fax: 617-750-5444 | |
Dr. Line Hviid, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1853 Commonwealth Ave, Suite 6, Brighton, MA 02135 Phone: 617-903-0360 | |
Devon Oosting, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 42 Strathmore Rd. Apt. 6, Brighton, MA 02135 Phone: 616-299-3082 | |
Beverly Corbett, ED.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 77b Warren St., Brighton, MA 02135 Phone: 617-787-1901 Fax: 617-254-3461 | |
Prof. Maureen Kenny, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 36 Cummings Rd Apt 3, Brighton, MA 02135 Phone: 617-552-4030 |